Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT02172482 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63127
Last updated 2014-06-24
Summary
As part of the post-marketing surveillance, information is to be gathered regarding the tolerance and efficacy of Spiriva® 18 micrograms in patients with COPD under conditions of daily practice
Conditions
- Pulmonary Disease, Chronic Obstructive
Interventions
- DRUG
-
Tiotropium bromide
Tiotropium bromide18 micrograms (capsule with powder for inhalation)
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-06-30
- Primary Completion
- 2003-10-31
More Related Trials
-
Spiriva® Assessment of FEV1 (SAFE)
NCT00277264 ·Status: COMPLETED ·Phase: PHASE3
-
Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders
NCT00274014 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients
NCT00274508 ·Status: COMPLETED ·Phase: PHASE3
-
SPIRIVA in Ususal Care
NCT00274079 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD
NCT00274053 ·Status: COMPLETED ·Phase: PHASE3
-
Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).
NCT00239408 ·Status: COMPLETED ·Phase: PHASE4
-
Special Survey Long-term Treatment With Tiotropium on COPD
NCT00638183 ·Status: COMPLETED
-
Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)
NCT00274027 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced Dyspnoea
NCT00540163 ·Status: COMPLETED
-
Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease
NCT02177318 ·Status: COMPLETED
-
A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT00144326 ·Status: COMPLETED ·Phase: PHASE3
-
Tiotropium (Spiriva) Rehabilitation Study
NCT00274521 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients
NCT00157235 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Chronic Obstructive Pulmonary Disease (COPD) Therapy From the Physicians Perspective Using Tiotropium as an Example
NCT01036763 ·Status: COMPLETED
-
Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients
NCT00144339 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines
NCT00615992 ·Status: COMPLETED
-
Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT03118765 ·Status: COMPLETED ·Phase: PHASE2
-
Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema
NCT00570544 ·Status: COMPLETED
-
Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT05986591 ·Status: COMPLETED ·Phase: PHASE3
-
A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).
NCT00784550 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary Disease
NCT01072396 ·Status: COMPLETED ·Phase: PHASE4
-
A Prescription-Event Monitoring (PEM) Study of Tiotropium
NCT02196194 ·Status: COMPLETED
-
Comparative Effectiveness of Symbicort vs. Spiriva Among COPD Patients
NCT01917643 ·Status: COMPLETED
-
Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD
NCT00239447 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence Study of Tiotropium Bromide Inhalation Powder
NCT05161156 ·Status: COMPLETED ·Phase: PHASE3